A comparative analysis of clinical manifestations of Alzheimer′s disease patients and Lewy body dementia patients

Junying Xu(Wuxi People's Hospital), Yong Ji(Tianjin Huanhu Hospital), Yujin Zhao(Shanghai Jiao Tong University), Zhihong Shi(First Affiliated Hospital of Xi'an Jiaotong University), Wenzheng Hu(Capital Medical University), Shuai Liu(Tongji University), Jinghuan Gan(Capital Medical University)
Zhonghua laonian yixue zazhi
June 14, 2018
10.3760/cma.j.issn.0254-9026.2018.06.007
Cited by 0

Related Papers

Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.8k
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study
|The Lancet|2019|773
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
|Journal of Neuroinflammation|2018|268
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia
|Alzheimer s Research & Therapy|2021|200
HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib
|Blood|2016|137